Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Immune Response Triggered by Honeybee Venom Supports Hypothesis on the Origin of Allergies

Published: Wednesday, November 27, 2013
Last Updated: Wednesday, November 27, 2013
Bookmark and Share
Allergy-like immune reactions could represent a mechanism of the body that protects it against toxins.

This surprising conclusion has been reached by scientists at Stanford University, USA, working on a research project co-financed by the Austrian Science Fund FWF. The recently published findings prove that honeybee venom triggers an immune response in mice associated with the formation of IgE antibodies, which are also typical for allergic responses. These IgEs then confer protection against higher amounts of the venom subsequently administered to the mice. Thus, for the first time, IgEs were observed as having a direct protective function against a venom - a finding that substantiates a controversial hypothesis on the emergence of allergies formulated in the 1990s.

Allergies are quite unnecessary: instead of fighting microbes that pose a threat to health, the immune system targets harmless pollens, hairs or dust particles. The question as to why the body puts up such a fight against harmless substances is one that preoccupies scientists all over the world. A study by an Erwin Schrödinger Fellow of the Austrian Science Fund FWF, which has been currently published in the journal Immunity, gives new impetus to a controversial hypothesis for the explanation of such allergic reactions.

Toxin Protects Against More Toxin
Dr. Philipp Starkl, who is using his fellowship to collaborate with Prof. Stephen J. Galli and his team at the Department of Pathology at Stanford University School of Medicine, summarises the results of the joint study as follows: "Mice, to whom we had previously administered small amounts of honeybee venom, subsequently displayed astonishing resistance to larger volumes of the toxin. As in the case with a vaccination, the body appeared to build a kind of immune protection against the bee venom." Interestingly, however, completely different responses in humans are also known - in some unfortunate people repeated contact with bee venom causes allergic reactions or even an anaphylactic shock. IgE-type antibodies are mainly responsible for this response.

Dr. Starkl and his colleagues investigated the question as to whether these antibodies are also involved in the reactions observed in mice. To establish this, honeybee venom was administered to three different mouse strains, in which the functioning of an immune reaction based on IgE was prevented in different ways. The results showed that, unlike the previously examined "normal" mice strains, these mice were unable to form any protection against honeybee venom. Therefore, IgEs seem to have a positive function in mice. This finding patently contradicts what was already known from humans, in who IgE antibodies are mainly seen as causing allergic reactions. It had been suspected that a positive function existed beyond this (for example in the immune response to parasites); however, it had not been possible to demonstrate it directly up to now.

Evolution Follows Function
The Stanford team though was not very surprised to discover this positive function of IgE. Dr. Starkl, who, together with his Belgian colleague Dr. Thomas Marichal, is co-first author of the current publication, explains: "In our view, the assumption that the function of IgE antibodies is limited to triggering allergic reactions always fell short of the mark. Otherwise, IgEs would surely have been eliminated in the course of evolution, a consideration that also underlies the so-called toxin hypothesis."

According to this hypothesis, the body can build protection against toxic substances using IgE antibodies and allergic reactions. Thus, IgEs would have fulfilled a very important role in human evolution - which only relinquished its significance with the development of increasingly protected lifestyles of humans. Furthermore, according to the hypothesis, allergic reactions are extreme or uncontrolled forms of the protection mechanism. The "underemployment" of this response in modern times could then actually contribute to its tendency to malfunction or overreact.

The toxin hypothesis, which was proposed by Margie Profet in 1991, has been hotly contested up to now - but never been refuted. The research carried out by the FWF Erwin Schrödinger Fellow now provides the first experimental finding that substantiates it - and demonstrates, once again, the importance of keeping an open mind in science.

The original publication can be accessed online.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
Friday, July 31, 2015
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
Thursday, July 30, 2015
Genetic Signature Enables Early, Accurate Sepsis Diagnosis
Systemic inflammation after injuries or surgery can dramatically alter the activity of thousands of genes, but a new study shows that changes in just 11 of them are enough to detect the presence or absence of accompanying infection.
Monday, May 18, 2015
Foreign Antibodies Mobilize Immune System to Fight Cancer
A mouse’s T cells can be primed to attack and eliminate a malignant tumor by injecting antibodies from another mouse with resistance to the tumor, as well as by activating certain signaling cells, a study has found.
Thursday, May 07, 2015
Stanford Research Leads to New Understanding of How Cells Grow and Shrink
Researchers use new techniques to document how cells can conceal growth and then suddenly swell up.
Saturday, May 17, 2014
DNA ‘Reverse’ Vaccine Reduces Levels of Immune Cells Believed Responsible For Type-1 Diabetes
A clinical trial of a vaccine has delivered initially promising results, suggesting that it may selectively counter the errant immune response that causes the diabetes.
Wednesday, July 03, 2013
Antibody Hinders Growth of Gleevec-Resistant Gastrointestinal Tumors in Lab Test
An antibody that binds to a molecule on the surface of a rare but deadly tumor of the gastrointestinal tract inhibits the growth of the cancer cells in mice.
Thursday, February 07, 2013
Lasker Award Goes to Biochemist James Spudich
Research helps to explain the molecular activity that enables heartbeats, makes muscles contract and powers immune cells.
Wednesday, September 12, 2012
Stanford Chemists Synthesize Compound that Flushes Out Latent HIV
A new collection of compounds, called "bryologs" - derived from a tiny marine organism - activate hidden reservoirs of the virus that currently make the disease nearly impossible to eradicate.
Monday, July 23, 2012
Stanford Scientist Omics Profile used to Discover, Track his Diabetes Onset
Researchers also spied on Dr Snyder's immune system and watched it battle viral infections.
Monday, March 19, 2012
Scientific News
Sorting Through Cellular Statistics
Aaron Dinner, professor in chemistry, and his graduate student Herman Gudjonson are trying to read the manual of life, DNA, as part of the Dinner group’s research into bioinformatics—the application of statistics to biological research.
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!